Management of Hashimoto's Thyroiditis in Pregnancy
Pregnant women with Hashimoto's thyroiditis require immediate levothyroxine dose adjustment upon pregnancy confirmation, increasing by 30% (typically two additional tablets per week), with TSH maintained below 2.5 mIU/L in the first trimester and below 3.0 mIU/L in subsequent trimesters. 1
Pre-Pregnancy Optimization
For women with known Hashimoto's thyroiditis planning pregnancy:
- Check TSH before conception and adjust levothyroxine to achieve TSH ≤2.5 mIU/L 1
- Counsel all women on levothyroxine to contact their physician immediately upon missed period or positive pregnancy test 1
- Instruct patients to empirically increase their levothyroxine dose by 30% (nine tablets per week instead of seven) as soon as pregnancy is suspected, pending TSH confirmation 1
Initial Pregnancy Management
For Women Already on Levothyroxine:
Immediate dose increase is critical - women with Hashimoto's thyroiditis typically need 30-50% more levothyroxine during pregnancy compared to pre-pregnancy doses 1. The increment is smaller in Hashimoto's patients (who retain some residual thyroid tissue) compared to those with complete thyroid ablation 1.
For Newly Diagnosed Hypothyroidism in Pregnancy:
Starting doses based on TSH level:
- TSH 2.5-10 mIU/L: Start 50 mcg/day or more 1
- TSH ≥10 mIU/L: Start 1.6 mcg/kg/day 2
- TSH <10 mIU/L: Start 1.0 mcg/kg/day 2
When TSH is first checked during pregnancy, use these increments 1:
- TSH 5-10 mIU/L: Add 25-50 mcg/day
- TSH 10-20 mIU/L: Add 50-75 mcg/day
- TSH >20 mIU/L: Add 75-100 mcg/day
Monitoring Protocol
TSH monitoring frequency is non-negotiable:
- Check TSH every 4 weeks after any dose adjustment until stable 2
- Once stable, continue monitoring at minimum once per trimester 2
- Measure both TSH and free T4 as soon as pregnancy is confirmed 2
Target TSH ranges:
Critical Pitfalls to Avoid
The most common management error is failing to increase levothyroxine promptly at pregnancy confirmation. Real-world evidence shows hypothyroidism in pregnancy is frequently overlooked or undertreated 3. The physiological increase in thyroid hormone requirements begins immediately with conception due to increased thyroid binding globulin from estrogen and placental metabolism of thyroid hormones.
Do not rely on standard non-pregnant reference ranges - TSH values that appear "normal" (0.4-4.0 mIU/L) may actually represent inadequate treatment in pregnancy 1. First trimester TSH should be substantially lower due to hCG-mediated thyroid stimulation.
Thyroid Antibody Considerations
Women with Hashimoto's thyroiditis (anti-TPO antibody positive) face increased risks even when euthyroid 1:
- Miscarriage
- Preterm delivery
- Progression to overt hypothyroidism
- Postpartum thyroiditis
However, universal screening for anti-TPO antibodies is not recommended 1. If antibodies are already known to be positive, monitor TSH before pregnancy and during first and second trimesters 1.
Postpartum Management
Immediately reduce levothyroxine to pre-pregnancy dose after delivery 2. This is essential to prevent thyrotoxicosis.
- Monitor TSH 4-8 weeks postpartum 2
- Women with Hashimoto's thyroiditis have markedly increased risk of postpartum thyroiditis - perform annual TSH monitoring long-term 1
- Approximately 40% of women with autoimmune thyroiditis may develop postpartum thyrotoxicosis, requiring temporary dose reduction to approximately 50% of baseline 4
Special Considerations
Residual thyroid function matters: Women with Hashimoto's thyroiditis who have more residual thyroid tissue (higher thyroid blood flow on ultrasound) may require smaller dose increases than those with minimal remaining function 5. However, this does not change the initial management approach - all pregnant women with Hashimoto's on levothyroxine need immediate dose escalation.
Levothyroxine is the only appropriate thyroid hormone replacement - T3-containing preparations are not recommended during pregnancy 1.